Will India mass-manufacture world's first COVID-19 vaccine Sputnik V? Russia asks for joint venture
Published
Researchers from Gamaleya National Institute has said that the vaccine has not produced any 'unforeseen or unwanted side effects' on the volunteers, adding that 'not a single participant of the current clinical trials got infected with COVID-19.'
Full Article